Revised SPC: Relestat (epinastine hydrochloride) 0.5 mg/ml, eye drops, solution

SPC updated to warn cases of corneal calcification have been reported very rarely in association with the use of phosphate containing eye drops such as Relestat, in some patients with significantly damaged corneas.

Source:

electronic Medicines compendium